Sepsis Clinical Decision Support [CDS] Master Enrollment Study Protocol

Part of paid clinical trials in Irvine, California.

Sponsor
Beckman Coulter, Inc.
Study ID
NCT05304728
Status
Enrolling By Invitation

Conditions

  • Severe Sepsis
  • Severe Sepsis Without Septic Shock

Eligibility Criteria

Sex
ALL
Age
18 Years - 89 Years
Healthy Volunteers
Not accepted

Study Details

This protocol will collect real-world data retrospectively from the electronic health record (EHR) as data obtained from the delivery of routine medical care to develop a machine learning (ML)-based Clinical Decision Support (CDS) system for severe sepsis prediction and detection.

Key Dates

Start date
Feb 15, 2021
Status verified
Jun 2024
Primary completion
Mar 30, 2025
Completion
Dec 31, 2026

Study Design

Enrollment
40,000 participants (estimated)

Arms

  • Arm: Primary Objective: Severe Sepsis
    The primary endpoint for this study is defined as the presence of sufficient data for SOWS training and algorithm development to proceed with subsequent validation. To provide sufficient data subsets (severe sepsis EHR encounters) for training and validation of the Sepsis Onset Warning System algorithm. There will not be any interventions administered.

Primary Outcome Measure

Severe Sepsis [ Time Frame: Within 6 hours from presentation to the emergency department ]

Locations (10)

FacilityCityStateZIPSite coordinators
University of California, IrvineIrvineCalifornia92697-
Augusta University Medical SchoolAugustaGeorgia30912-
Indiana University HealthIndianapolisIndiana46202-5200-
University Health/ Truman Medical CenterKansas CityMissouri64108-
University of Kansas Medical CenterKansas CityMissouri66103-
Hackensack University Medical CenterHackensackNew Jersey07601-
WakeMed HealthRaleighNorth Carolina27610-
University of CininnatiCincinnatiOhio45221-
MetroHealth SystemsClevelandOhio44109-
The Ohio State UniversityColumbusOhio43210-

Find similar trials in Irvine, CA

Related Studies